Navigation Links
NCI renews Mayo Clinic Cancer Center support grant, extends comprehensive status
Date:7/6/2009

ROCHESTER, Minn. -- The Mayo Clinic Cancer Center (MCCC) received an additional five years of National Cancer Institute (NCI) funding and re-designation as a comprehensive cancer center, according to Robert Diasio, M.D., the center's director. Mayo Clinic has the only NCI-designated comprehensive cancer center conducting research at three distinct locations across the United States.

The NCI Cancer Center Support Grant award to MCCC totals more than $28 million over five years for infrastructure and administrative support for cancer center researchers across Mayo's three sites in Minnesota, Florida and Arizona.

"The NCI renewal of Mayo's Cancer Center Support Grant ensures the continuity of research programs that contribute to improved medical options for cancer patients," Dr. Diasio says. "This NCI grant is key in enabling Mayo Clinic to continue delivering outstanding care for its cancer patients."

The MCCC is headquartered in Rochester, Minn., with research campuses in Scottsdale, Ariz., and Jacksonville, Fla. With NCI approval in 2003, MCCC incorporated its cancer research activity at its Minnesota, Florida and Arizona sites into a single, integrated institution.

"The NCI recognized the Mayo Clinic Cancer Center for excellence in basic and clinical research, and for our contributions to cancer prevention, control and population sciences," Dr. Diasio says. "This award enables Mayo cancer researchers on all three of our campuses to build upon knowledge that leads to changes in medical practice which means improved treatment opportunities for our patients."

Within its scope as a NCI-designated comprehensive cancer center, the MCCC designs and develops translational clinical studies that arise from collaborations between scientists and physicians.

The 450 scientists and physicians of the MCCC faculty across all three sites are organized into programs that focus on 12 key cancer research themes. They include Women's Cancers, Neuro-Oncology, Hematologic (bloodborne) Malignancies, Gene and Virus Therapy, Developmental Therapeutics, Genetic Epidemiology and Risk Assessment, Immunology and Immunotherapy, Gastrointestinal Cancers, Prostate Cancer, Cell Biology, Cancer Imaging, and Cancer Prevention and Control.


'/>"/>

Contact: Karl Oestreich
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Related medicine news :

1. Cardinal Health Renews Distribution Agreement With CVS Caremark
2. The European Association for the Study of the Liver renews publishing partnership with Elsevier
3. Nuvilex Renews MedX Master Distribution Agreement and Implements New Pricing for Talsyn Scar Cream
4. DC Government Renews Certified Business Enterprise Classification to Language Interpretation and Translation Firm
5. New York Merchants Protective Co. Renews CSAA Five Diamond Certification
6. Specialists On Call Renews Joint Commission Accreditation
7. New book series renews call for ban on gambling
8. Doctor Diabetic Supply, Inc. Renews its ACHC Accreditation
9. American TeleCare, Inc. (ATI) Renews Agreements for its Telehealth Solutions with the Veterans Health Administration
10. Rochester Medical Renews Share Repurchase Activity
11. Clarient Renews and Expands Mezzanine Credit Facility With Safeguard
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) ... a collection of specialty vendors and unique items from across the nation, this holiday-themed ... and wellness services offered by the VNA. The boutique will be open Saturday, ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/13/2017)... ... ... Journey: From the Mountains to the Mission Field”: the story of a missionary couple ... From the Mountains to the Mission Field” is the creation of published author, Carole ... and currently teaches a class of ladies at her church, which she has taught ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco dentists, ... cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated to ... breathing. Oral appliances can offer significant relief to about 75 percent of people ...
(Date:10/12/2017)... ... 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of ... innovative new design of the shoulder pad. The shoulder pad provides optimal support ... your pain while using cold therapy. By utilizing ice and water that is circulated ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... -- The Rebound mobile app is poised to become a ... of prescription drug addiction. The app empowers users to develop ... down their dosage in a safe, controlled manner while maximizing ... first 100,000 people to sign up will enjoy 3 months ... ...
(Date:9/27/2017)... their devotion to personalized service, SMP Pharmacy Solutions announces their ... South Florida Business Journal,s 50 Fastest-Growing Companies, and listed for ... specialty pharmacy has found its niche.  To that end, the ... by SFBJ as the 2017 Power Leader in Health Care. ... award in October, Bardisa said of the three achievements, "It,s ...
(Date:9/25/2017)... Sept. 25, 2017  EpiVax, Inc., a leader ... and immune-engineering today announced the launch of EpiVax ... of personalized therapeutic cancer vaccines. EpiVax has provided ... access to enabling technologies to the new precision ... lead EpiVax Oncology as Chief Executive Officer. Gad ...
Breaking Medicine Technology: